We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -18.87% | 1.075 | 1.05 | 1.10 | 1.325 | 1.075 | 1.33 | 3,076,199 | 10:19:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.25 | 10.24M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/5/2020 16:06 | Some investors probably got scared out of this now due to how it can swing by so much i.e. 200p to 50p. Hopefully only positive news from now on | 78steve | |
15/5/2020 14:07 | Do you think they want that hearing out of the way on 23rd June so as not to put a dampener on it perhaps? I believe it's not related to US or China only Europe, but nonetheless could have some impact.. | daveboy1 | |
15/5/2020 13:43 | can't believe we haven't seen a steady rise this week. I've got loads of these but have done 2 further top ups this week in anticipation of a US deal in the next month or so IMHO. Anything under £1.50 is a massive bargain based on size of US market and imminent deal. Last few RNSs have dropped the hints that this is not too far away | shandypants2 | |
15/5/2020 10:08 | Yes, just briefed my son on them in case I've lost my marbles by the time there is any action of a positive nature !! | daveboy1 | |
15/5/2020 09:26 | All good things come to those that wait And wait !!! | peachie 74 | |
15/5/2020 08:21 | Looks like another thriller in store for us here today. | daveboy1 | |
14/5/2020 09:08 | Mentioned again on the radio it will be months before normal hospital procedures can recommence, including cancer treatment and surgery. So where will IV iron infusions be ? Non existent or severely limited for a long time to come. Surely Feraccru has had to benefit here.. And once people try it, I’m sure they won’t be rushing back to IV | peachie 74 | |
13/5/2020 10:03 | Ah,rapture, another gardening day. Although immaculate already ! | daveboy1 | |
12/5/2020 14:20 | Agreed - hopefully some good news arriving this quarter. Incidentally, LSE has nearly twice as many shares bought than sold! | daveboy1 | |
12/5/2020 13:48 | Yes. MMS playing games. No volume and they aren’t bothered. People who have researched this will know just how massive this could be. Hence no real selling. Not many shares in PI hands. It’s just going to need something to spark interest ( ie US deal ) to get people into the share, research it and see how the US deal will just be the start hopefully Iron deficiency is massive worldwide. IV iron has so many limitations. These tablets can take over a billion dollar market if guided right. Fingers crossed for the holders. | peachie 74 | |
12/5/2020 11:15 | It goes down 7.5p on less sells than yesterday's buys when it moved 0.5p up on the bell. Curious. | daveboy1 | |
11/5/2020 16:17 | "US licensing deal: Although stepping down, the founder and former CEO has agreed to support the licensing process in the US so that the current positive momentum is not lost. We understand that there is a strong shortlist of potential partners." Strong shortlist of potential partners sounds promising too | peachie 74 | |
11/5/2020 15:06 | Yes they say US commercialisation deal on 2 months..tick tock! | ny boy | |
11/5/2020 14:56 | New trading update from Hardman Research | peachie 74 | |
07/5/2020 13:00 | How do you know they have no plan to replace them ? Did I miss that in the RNS ? Tim Watts could well fulfill the role well. He may be temporary. None of that info will be in the public domain. Or are we treading water until a takeover ? | peachie 74 | |
07/5/2020 12:45 | >> cranky man Good point. It does make you wonder what the future plan is.... | nobbygnome | |
07/5/2020 12:35 | No CEO no Medical Director . No plan to replace them. It’s just about sweating this asset. They don’t need these medical or commercial guys anymore. It’s a holding company for Feraccru. No problem for me. | crankyman | |
07/5/2020 12:16 | I’d rather it be stuck here than in the 80s like it was not along ago though ! Returning to the point of winding down as a development company, Feraccru and PT20 have been the main 2 developments for ever basically. They have more than enough meat on the bone with these 2 products. They have never been a developer of new products ?? | peachie 74 | |
07/5/2020 12:11 | Don’t you just love these MM’s, keep the spread wide and the bid low to try and mug a few more investors jeez! Lolz | ny boy | |
07/5/2020 12:06 | Yep, interesting perspective! Seems like share price stuck in a rut atm though. | daveboy1 | |
07/5/2020 10:15 | Winding down. Really ?! Is the push in China winding down US deal winding down ! PT20 development winding down ! Covid related delay on paediatrics winding down !? You after some cheaper shares Cranky ! | peachie 74 | |
07/5/2020 09:16 | I wouldn't spend too much time dissecting these scripted interviews. He even said "readers" when he should have said "viewers". It's just another holding statement. I'm sure he's reasonably competent. Both medical director and CEO have gone. Paediatric study on hold. This company is winding down as a development organisation. Fair enough. They did amazingly well. Tiny slip up at the end. | crankyman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions